Michael Szelke
17Patents
10h-index
16Co-inventors
69Inventor score
Filing activity: Jul 10, 1978 → Apr 21, 1999
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5939560A | Inhibitors of DP-mediated processes, compositions and therapeutic methods thereof | Chemistry; Metallurgy | 114 | Expired |
| US6201132A | Inhibitors of DP-mediated processes, compositions, and therapeutic methods thereof | Chemistry; Metallurgy | 63 | Expired |
| US4424207A | Enzyme inhibitors | Emerging Cross-Sectional Technologies | 32 | Expired |
| US4304715A | Enkephalin analogues | Chemistry; Metallurgy | 30 | Expired |
| US4638047A | Enzyme inhibition | Emerging Cross-Sectional Technologies | 23 | Expired |
| US4609643A | Renin inhibitors, treatments and dipeptide synthesis | Emerging Cross-Sectional Technologies | 17 | Expired |
| US4198398A | Enkephalin analogues | Human Necessities | 15 | Expired |
| US4650661A | Enzyme inhibitors | Emerging Cross-Sectional Technologies | 14 | Expired |
| US4713445A | Renin inhibitors and treatments using them | Emerging Cross-Sectional Technologies | 13 | Expired |
| US4242256A | Synthesis of peptide analogues | Chemistry; Metallurgy | 11 | Expired |
| US4772686A | Enzyme inhibition | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5688943A | Benzodiazepine derivatives useful as CCK-receptor antagonists | Chemistry; Metallurgy | 4 | Expired |
| US6096712A | Kininogen inhibitors | Human Necessities | 3 | Expired |
| US5728829A | Process of preparing benzodiazepine compounds useful as antagonists of CCK or of gastrine | Chemistry; Metallurgy | 3 | Expired |
| US5962451A | Benzodiazepin derivatives useful as CCK-receptor antagonists | Chemistry; Metallurgy | 3 | Expired |
| US5424291A | Isosteric peptides | Human Necessities | 3 | Expired |
| USRE30731E | Enkephalin analogues | General | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.